Searchable abstracts of presentations at key conferences in endocrinology

ea0020oc3.4 | Reproduction/Stress/Endocrine Disruptors | ECE2009

Reference ranges for sex hormone-binding globulin and free testosterone index in adult men

Friedrich Nele , Volzke Henry , Krebs Alexander , Nauck Matthias , Wallaschofski Henri

Objective: The majority of circulating testosterone is bound to sex hormone-binding globulin (SHBG), but also to albumin and cortisol-binding globulin. The remaining part is free-circulating testosterone unattached to serum proteins, which represents the active form of the hormone. A common measurement of the free testosterone is the calculated free testosterone index (FTI)=100*(total testosterone/SHBG). Testosterone is the principal male sex hormone and is involved in the reg...

ea0016p370 | Growth factors | ECE2008

Associations of anthropometric parameters with serum IGF-1, TSH, prolactin and testosterone levels

Friedrich Nele , Steveling Antje , Nauck Matthias , Brabant Georg , Volzke Henry , Wallaschofski Henri

Background: Obesity is a major risk factor for the development of chronic diseases and a determinant of cardiovascular disease. Divergent associations between obesity and hormonal changes have been reported. The objective of the present study was to analyse the associations between different anthropometric measurements and serum hormone levels including insulin-like growth factor 1 (IGF-1), thyroid-stimulation hormone (TSH), prolactin, and testosterone.M...

ea0016p372 | Growth factors | ECE2008

Acromegaly is associated with high plasma fibrinogen and C reactive protein values after normalization of growth hormone and IGF-1

Friedrich Nele , Nonnenberg Dennis , Spilcke-Liss Elisabeth , Volzke Henry , Dorr Marcus , Wallaschofski Henri

Background: Acromegaly is associated with increased morbidity and mortality from cardiovascular disease. Several studies indicate that reduction of growth hormone (GH) to <1 μg/l or normalization of serum IGF-I reduces mortality to expected levels. Inflammatory markers, such as C-reactive protein (CRP) or haemostatic markers, such as fibrinogen have emerged as important cardiovascular risk markers in the general population.Objective and design: ...

ea0056p542 | Obesity | ECE2018

Associations of circulating adipokine levels with metabolic risk factors and renal function in a general population

Zylla Stephanie , Fischer Julian , Volzke Henry , Kassubek Jan , Kuhn Jens-Peter , Nauck Matthias , Friedrich Nele

Background, objective: Adipose tissue is known to secrete a multitude of bioactive adipokines and it seems that the majority of these adipokines is implicated in the pathogenesis of obesity and associated metabolic diseases. Existing research studies mostly concentrated on one or two adipokines and therefore, comparisons of the involvement of different adipokines in these disorders are difficult. Furthermore, associations of circulating adipokine levels with different fat comp...

ea0041oc4.2 | Thyroid - Clinical | ECE2016

Molecular fingerprint of experimental thyrotoxicosis on human metabolism: combined metabolome and proteome study

Pietzner Maik , Engelmann Beatrice , Kacprowski Tim , Golchert Janine , Dirk Anna-Luise , Homuth Georg , Hammer Elke , Nauck Matthias , Wallaschofski Henri , Munte Thomas , Friedrich Nele , Volker Uwe , Brabant Georg

The functional state of the thyroid is usually determined by thyrotropin (TSH), whose serum levels depend on circulating thyroid hormone (TH) levels. This feedback mechanism is tightly controlled in the individual and contrasts broad reference range for TSH in the general population, leading to the concept of subclinical thyroid disease. We studied a model of experimental thyrotoxicosis in humans employing an untargeted metabolome and proteome approach. This allowed us to gain...

ea0056p1040 | Thyroid (non-cancer) | ECE2018

A thyroid hormone-independent molecular fingerprint of 3,5-diiodothyronine suggests a strong relation with coffee metabolism in humans

Pietzner Maik , Homuth Georg , Kohrle Josef , Budde Kathrin , Kastenmuller Gabi , Brabant Georg , Volzke Henry , Artati Anna , Adamski Jerzy , Volker Uwe , Nauck Matthias , Friedrich Nele

Background: Numerous animal models have shown impressive beneficial metabolic effects of the putative thyroid hormone (TH)-derivative 3,5-diiodothyronine (3,5-T2), including the prevention of insulin resistance or the reversal of hepatic steatosis, in the absence of thyrotoxic side effects. In contrast, the endogenous fate of 3,5-T2 in humans is still unclear. Comprehensive molecular profiling holds promise to gain deeper insights in metabolic alterations associated with serum...